Progestational agents to prevent preterm birth: A meta-analysis of randomized controlled trials

Obstetrics and Gynecology

Volumn 105, Issue 2, 2005, Pages 273-279

  Sanchez Ramos, Luis ^a,b   Kaunitz, Andrew M ^a   Delke, Isaac ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; HEXANOIC ACID; HYDROXYPROGESTERONE; PLACEBO; RITODRINE; UTERUS SPASMOLYTIC AGENT;

BIRTH WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DELIVERY; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; LOW BIRTH WEIGHT; META ANALYSIS; OUTCOMES RESEARCH; PERINATAL MORTALITY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; INCIDENCE; MEDROXYPROGESTERONE 17-ACETATE; ODDS RATIO; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS; REFERENCE VALUES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 13644259104     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000150559.59531.b2     Document Type: Review

References (29)

1. Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM. Births: final data for 2000. Natl Vital Stat Rep 2002;50:1-102.
2. King JF, Grant AM, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: an overview of randomized controlled trials. Br J Obstet Gynaecol 1988;95:211-22.
3. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
4. O'Leary JA. Prophylactic tocolysis of twins. Am J Obstet Gynecol 1986;154:904-5.
5. Allbert JR, Wise CA, Lou CH, Gookin KS, Parmenter MA, Morrison JC. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth. J Perinatol 1992;12:28-31.
6. Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990;97:149-54.
7. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, et al. Prevention of recurrent preterm delivery by 17α-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-85.
8. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24.
9. Goldstein P, Berrier J, Rosen S, Sacks HS, Chalmers TC. A meta-analysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 1989;96:265-74.
10. Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage: a meta-analysis of controlled trials. Br J Obstet Gynaecol 1989;96:275-80.
11. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354:1896-900.
12. Schulz KF, Chalmers I, Haves R, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
13. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies. J Natl Cancer Inst 1959;22:719-48.
14. DerSimonian R, Laird N. Meta-analyses in clinical trials. Control Clin Trials 1986;7:177-88.
15. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107:224-33.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
17. Noblot G, Andra P, Dargent D, Faguer B, Mellier G. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 1991;40:203-9.
18. Kauppila A, Hartikainen-Sorri A, Janne O, Tuimala R, Jarvinen PA. Suppression of threatened premature labor by administration of cortisol and 17α-hydroxyprogesterone caproate: a comparison with ritodrine. Am J Obstet Gynecol 1980;138:404-8.
19. Breart G, Lanfranchi M, Chavigny C, Rumeau-Rouquette C, Sureau C. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor. Int J Gynaecol Obstet 1979;16:381-4.
20. Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 1986;154:525-9.
21. Tapil'skaia NI, Petrosian MA, Lesik EA. Therapeutic efficacy of novel 17 α-hydroxyprogesterone derivatives in experimental preterm labor [in Russian]. Eksp Klin Farmakol 2002;65:44-5.
22. Corrado F, Dugo C, Cannata ML, Bartolo MD, Scilipoti A, Stella NC. A randomized trial of progesterone prophylaxis after midtrimester amniocentesis. Eur J Obstet Gynecol Reprod Biol 2002;100:196-8.
23. Hauth JC, Gilstrap LC, Brekken AL, Hauth JM. The effect of 17 α-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol 1983;146:187-90.
24. Johnson JWC, Austin KL, Jones GS, Davis G, King TM. Efficacy of 17 α-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975;293:675-80.
25. Yemini M, Borenstein R, Dreazen E, Apelman B, Mogilner M, Kessler I, et al. Prevention of premature labor by 17 α-hydroxyprogesterone caproate. Am J Obstet Gynecol 1985;151:574-7.
26. Hartikainen-Sorri AL, Kauppila A, Tuimala R. Inefficacy of 17 α-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980;56:692-5.
27. Goldzieher JW. Double-blind trial of a progestin in habitual abortion. JAMA 1964;188:651-5.
28. Tognoni G, Ferrario L, Inzalaco M. Progestagens in threatened abortion. Lancet 1980;2:1242-3.
29. LeVine L. Habitual abortion: a controlled clinical study of progestational therapy. West J Surg 1964;72:30-6.